| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.06 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.33 | 0.06 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |